BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thyagarajan A, Shaban A, Sahu RP. MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention. J Pharmacol Exp Ther. 2018;364:1-12. [PMID: 29054858 DOI: 10.1124/jpet.117.242636] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun MX, An Q, Chen LM, Guo L. MIR-520f Regulated Itch Expression and Promoted Cell Proliferation in Human Melanoma Cells. Dose Response 2020;18:1559325820918450. [PMID: 32425721 DOI: 10.1177/1559325820918450] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
2 Liu G, Li C, Zhen H, Zhang Z, Sha Y. Identification of prognostic gene biomarkers for metastatic skin cancer using data mining. Biomed Rep 2020;13:22-30. [PMID: 32494360 DOI: 10.3892/br.2020.1307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Li B, Shen M, Yao H, Chen X, Xiao Z. Long Noncoding RNA TP73-AS1 Modulates Medulloblastoma Progression In Vitro And In Vivo By Sponging miR-494-3p And Targeting EIF5A2. Onco Targets Ther 2019;12:9873-85. [PMID: 31819485 DOI: 10.2147/OTT.S228305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
4 Qin RF, Zhang J, Huo HR, Yuan ZJ, Xue JD. MiR-205 mediated APC regulation contributes to pancreatic cancer cell proliferation. World J Gastroenterol 2019; 25(28): 3775-3786 [PMID: 31391772 DOI: 10.3748/wjg.v25.i28.3775] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
5 Lu W, Tao X, Fan Y, Tang Y, Xu X, Fan S, Huang Y, Yu Y, Luo D. LINC00888 promoted tumorigenicity of melanoma via miR-126/CRK signaling axis. Onco Targets Ther 2018;11:4431-42. [PMID: 30104884 DOI: 10.2147/OTT.S164711] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
6 Li S, Stöckl S, Lukas C, Herrmann M, Brochhausen C, König MA, Johnstone B, Grässel S. Curcumin-primed human BMSC-derived extracellular vesicles reverse IL-1β-induced catabolic responses of OA chondrocytes by upregulating miR-126-3p. Stem Cell Res Ther 2021;12:252. [PMID: 33926561 DOI: 10.1186/s13287-021-02317-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Fornabaio G, Barnhill RL, Lugassy C, Bentolila LA, Cassoux N, Roman-Roman S, Alsafadi S, Del Bene F. Angiotropism and extravascular migratory metastasis in cutaneous and uveal melanoma progression in a zebrafish model. Sci Rep 2018;8:10448. [PMID: 29992995 DOI: 10.1038/s41598-018-28515-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
8 Rajendrakumar SK, Uthaman S, Cho C, Park I. Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment. Biomacromolecules 2018;19:1869-87. [DOI: 10.1021/acs.biomac.8b00460] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 10.7] [Reference Citation Analysis]
9 Zhang W, Zhao W, Ge C, Li X, Yang X, Xiang Y, Sun Z. Decreased let-7b is associated with poor prognosis in glioma. Medicine (Baltimore) 2019;98:e15784. [PMID: 31145301 DOI: 10.1097/MD.0000000000015784] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Thyagarajan A, Tsai KY, Sahu RP. MicroRNA heterogeneity in melanoma progression. Semin Cancer Biol 2019;59:208-20. [PMID: 31163254 DOI: 10.1016/j.semcancer.2019.05.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
11 Yin X, Huo Z, Yan S, Wang Z, Yang T, Wu H, Zhang Z. MiR-205 Inhibits Sporadic Vestibular Schwannoma Cell Proliferation by Targeting Cyclin-Dependent Kinase 14. World Neurosurg 2021;147:e25-31. [PMID: 33217595 DOI: 10.1016/j.wneu.2020.11.043] [Reference Citation Analysis]
12 Malekan M, Ebrahimzadeh MA, Sheida F. The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma. Biomed Pharmacother 2021;141:111873. [PMID: 34225012 DOI: 10.1016/j.biopha.2021.111873] [Reference Citation Analysis]
13 Boscaino V, Fiannaca A, La Paglia L, La Rosa M, Rizzo R, Urso A. MiRNA therapeutics based on logic circuits of biological pathways. BMC Bioinformatics 2019;20:344. [PMID: 31757209 DOI: 10.1186/s12859-019-2881-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Takashima Y, Kawaguchi A, Iwadate Y, Hondoh H, Fukai J, Kajiwara K, Hayano A, Yamanaka R. MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma. PLoS One 2019;14:e0210400. [PMID: 30615673 DOI: 10.1371/journal.pone.0210400] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
15 Tian P, Tao L, Wang Y, Han X. MicroRNA-127 Inhibits the Progression of Melanoma by Downregulating Delta-Like Homologue 1. Biomed Res Int 2020;2020:8523465. [PMID: 32051829 DOI: 10.1155/2020/8523465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Li Q, Zhang LY, Wu S, Huang C, Liu J, Wang P, Cao Y. Bioinformatics Analysis Identifies MicroRNAs and Target Genes Associated with Prognosis in Patients with Melanoma. Med Sci Monit 2019;25:7784-94. [PMID: 31621692 DOI: 10.12659/MSM.917082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Nabipoorashrafi SA, Shomali N, Sadat-Hatamnezhad L, Mahami-Oskouei M, Mahmoudi J, Sandoghchian Shotorbani B, Akbari M, Xu H, Sandoghchian Shotorbani S. miR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro. IUBMB Life 2020;72:2034-44. [PMID: 32687246 DOI: 10.1002/iub.2345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
18 DiVincenzo MJ, Latchana N, Abrams Z, Moufawad M, Regan-Fendt K, Courtney NB, Howard JH, Gru AA, Zhang X, Fadda P, Carson WE. Tissue microRNA expression profiling in hepatic and pulmonary metastatic melanoma. Melanoma Res 2020;30:455-64. [PMID: 32804708 DOI: 10.1097/CMR.0000000000000692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Tang K, Tang H, Du Y, Tian T, Xiong S. MiR-638 suppresses the progression of oral squamous cell carcinoma through wnt/β-catenin pathway by targeting phospholipase D1. Artificial Cells, Nanomedicine, and Biotechnology 2019;47:3278-85. [DOI: 10.1080/21691401.2019.1647222] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
20 Hallajzadeh J, Amirani E, Mirzaei H, Shafabakhsh R, Mirhashemi SM, Sharifi M, Yousefi B, Mansournia MA, Asemi Z. Circular RNAs: new genetic tools in melanoma. Biomark Med 2020;14:563-71. [PMID: 32462914 DOI: 10.2217/bmm-2019-0567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
21 Ho PY, Duan Z, Batra N, Jilek JL, Tu MJ, Qiu JX, Hu Z, Wun T, Lara PN, DeVere White RW, Chen HW, Yu AM. Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy. J Pharmacol Exp Ther 2018;365:494-506. [PMID: 29602831 DOI: 10.1124/jpet.118.247775] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
22 Takashima Y, Kawaguchi A, Iwadate Y, Hondoh H, Fukai J, Kajiwara K, Hayano A, Yamanaka R. miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma. PLoS One 2020;15:e0229577. [PMID: 32101576 DOI: 10.1371/journal.pone.0229577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Quiohilag K, Caie P, Oniscu A, Brenn T, Harrison D. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers. Virchows Arch 2020;477:121-30. [PMID: 32388720 DOI: 10.1007/s00428-020-02817-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Wu P, Kong L, Li J. MicroRNA-494-3p protects rat cardiomyocytes against septic shock via PTEN. Exp Ther Med 2019;17:1706-16. [PMID: 30783439 DOI: 10.3892/etm.2018.7116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
25 Donnelly D 3rd, Aung PP, Jour G. The "-OMICS" facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers. Semin Cancer Biol 2019;59:165-74. [PMID: 31295564 DOI: 10.1016/j.semcancer.2019.06.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
26 Zhao X, Wang Q, Lin F, Wang X, Wang Y, Wang J, Wang C. RNA Sequencing of Osteosarcoma Gene Expression Profile Revealed that miR-214-3p Facilitates Osteosarcoma Cell Proliferation via Targeting Ubiquinol-Cytochrome c Reductase Core Protein 1 (UQCRC1). Med Sci Monit 2019;25:4982-91. [PMID: 31276465 DOI: 10.12659/MSM.917375] [Reference Citation Analysis]